About Careers Internship MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

NICE Approves The New Class Of Breast Cancer Drugs

by Medindia Content Team on August 11, 2006 at 1:44 AM
Font : A-A+

NICE Approves The New Class Of Breast Cancer Drugs

A new class of breast cancer drugs had yesterday won the final draft of approval for use in the NHS alongside the 'gold standard' Tamoxifen.

The National Institute for Health and Clinical Excellence (Nice) had issued a final draft on the appraisal for the use of three types of aromatase inhibitors in postmenopausal women with early breast cancer. It was explained that these drugs would act by reducing the risk of tumors spreading after surgery and might benefit thousands of women with hormone receptor positive early breast cancer.

Advertisement

It was reported that the three drugs were Arimidex (anastrozole), Femara (letrozole), and Aromasin (exemestane) and will be available on the NHS alongside the "gold standard" drug Tamoxifen. It was also explained that though there is still the probability of the final guidance subjected to an appeal, it would be highly unlikely to be stopped at this stage. The inhibitors act by stopping the natural production of oestrogen, which is the hormone that is responsible for the growth and recurrence of many breast cancers.

Reports have indicated that a study conducted in, co-ordinated by Cancer Research UK, had found that patients who switched from Tamoxifen to Aromasin halfway through treatment had reduced the risk of the disease recurring by a third. It was also stated that in June, the landmark Intergroup Exemestane Study had also found that switching over to Aromasin had cut the risk of death by 17%, when compared with those who remained on Tamoxifen.
Advertisement

A trial with Arimidex that was given immediately after surgery had showed an extra 26% reduction in recurrence of cancer further to the 50% reduction provided by Tamoxifen. Studies have also shown that Femara is also more effective than Tamoxifen in a number of studies. The government had already announced that the doctors could use the drugs as they see fit, without waiting for recommendation from NICE.

Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
What's New on Medindia
Test Your Knowledge About Chromosomes?
Eating During Sunlight Hours Minimizes Mood Vulnerabilities
Know More About the Digestive System
View all
Recommended Reading
News Archive
Date
Category
Advertisement
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Women and Cancer Drug Toxicity Breast Biopsy Pagets disease of the breast Mastitis Cancer and Homeopathy Signature Drug Toxicity Breast Cancer Facts Cancer Facts Cancer 

Most Popular on Medindia

The Essence of Yoga Color Blindness Calculator Sinopril (2mg) (Lacidipine) Find a Hospital Indian Medical Journals Nutam (400mg) (Piracetam) Pregnancy Confirmation Calculator Blood - Sugar Chart Drug Side Effects Calculator Find a Doctor
This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use
×

NICE Approves The New Class Of Breast Cancer Drugs Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests